PMID: 15244523Jul 13, 2004Paper

High frequency of acute promyelocytic leukemia in northwest Iran

Asian Pacific Journal of Cancer Prevention : APJCP
Jamal Eivazi Ziaei

Abstract

Acute promyelocytic leukemia (APL) or M3 is a subtype of acute myeloid leukemia, according to the French-American-British group classification. High frequencies of APL have been reported previously by many investigators. We here studied AML patients to determine the frequency of APL in Tabriz in northwest Iran. We reviewed 483 AML patients from 1996-2003. M2 and M3 cases accounted for 43.4% and 19.4% of the total, respectively. Our study thus provides further evidence of high frequencies of APL associated with geographical areas. Further studies should now be performed to evaluate genetic and environmental predisposing factors in Iran.

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.